2016
Radley, D., Saah, A. and Stanley, M., 2016. Persistent infection with human papillomavirus 16 or 18 is strongly linked with high-grade cervical disease. Hum Vaccin Immunother, v. 12
Doi: http://doi.org/10.1080/21645515.2015.1088616
Hernández-Ávila, M., Torres-Ibarra, L., Stanley, M., Salmerón, J., Cruz-Valdez, A., Muñoz, N., Herrero, R., Villaseñor-Ruíz, IF. and Lazcano-Ponce, E., 2016. Evaluation of the immunogenicity of the quadrivalent HPV vaccine using 2 versus 3 doses at month 21: An epidemiological surveillance mechanism for alternate vaccination schemes. Hum Vaccin Immunother, v. 12
Doi: http://doi.org/10.1080/21645515.2015.1058458
Van Damme, P., Bonanni, P., Bosch, FX., Joura, E., Kjaer, SK., Meijer, CJLM., Petry, K-U., Soubeyrand, B., Verstraeten, T. and Stanley, M., 2016. Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines. Vaccine, v. 34
Doi: http://doi.org/10.1016/j.vaccine.2015.12.063
Hendry, M., Pasterfield, D., Adams, R., Evans, M., Fiander, A., Robling, M., Campbell, C., Makin, M., Gollins, S., Hiscock, J., Nafees, S., Bekkers, M-J., Rose, J., Williams, O., Stanley, M. and Wilkinson, C., 2016. Talking about human papillomavirus and cancer: protocol for a patient-centred study to develop scripted consultations. BMJ Open, v. 6
Doi: http://doi.org/10.1136/bmjopen-2016-011205
Van Damme, P., Bonanni, P., Bosch, FX., Joura, E., Kjaer, SK., Meijer, CJLM., Petry, K-U., Soubeyrand, B., Verstraeten, T. and Stanley, M., 2016. Corrigendum to "Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines" [Vaccine 34 (2016) 757-761]. Vaccine, v. 34
Doi: http://doi.org/10.1016/j.vaccine.2016.07.035
2015
Garland, SM., Subasinghe, AK., Jayasinghe, YL., Wark, JD., Moscicki, A-B., Singer, A., Bosch, X., Cusack, K. and Stanley, M., 2015. HPV vaccination for victims of childhood sexual abuse. Lancet, v. 386
Doi: http://doi.org/10.1016/S0140-6736(15)00757-6
Lowy, DR., Herrero, R., Hildesheim, A. and Participants in the IARC/NCI workshop on Primary Endpoints for Prophylactic HPV Vaccine Trials, , 2015. Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging. Lancet Oncol, v. 16
Doi: http://doi.org/10.1016/S1470-2045(15)70075-6
2014
Lazcano-Ponce, E., Stanley, M., Muñoz, N., Torres, L., Cruz-Valdez, A., Salmerón, J., Rojas, R., Herrero, R. and Hernández-Ávila, M., 2014. Overcoming barriers to HPV vaccination: non-inferiority of antibody response to human papillomavirus 16/18 vaccine in adolescents vaccinated with a two-dose vs. a three-dose schedule at 21 months. Vaccine, v. 32
Doi: http://doi.org/10.1016/j.vaccine.2013.11.059
Lazcano-Ponce, E., Stanley, M., Muñoz, N., Torres, L., Cruz-Valdez, A., Salmerón, J., Rojas, R., Herrero, R. and Hernández-Ávila, M., 2014. Overcoming barriers to HPV vaccination: Non-inferiority of antibody response to human papillomavirus 16/18 vaccine in adolescents vaccinated with a two-dose vs. a three-dose schedule at 21 months Vaccine, v. 32
Doi: http://doi.org/10.1016/j.vaccine.2013.11.059
Stanley, M., 2014. HPV vaccination in boys and men. Hum Vaccin Immunother, v. 10
2013
Bosch, FX., Broker, TR., Forman, D., Moscicki, A-B., Gillison, ML., Doorbar, J., Stern, PL., Stanley, M., Arbyn, M., Poljak, M., Cuzick, J., Castle, PE., Schiller, JT., Markowitz, LE., Fisher, WA., Canfell, K., Denny, LA., Franco, EL., Steben, M., Kane, MA., Schiffman, M., Meijer, CJLM., Sankaranarayanan, R., Castellsagué, X., Kim, JJ., Brotons, M., Alemany, L., Albero, G., Diaz, M., de Sanjosé, S. and authors of ICO Monograph Comprehensive Control of HPV Infections and Related Diseases Vaccine Volume 30, Supplement 5, 2012, , 2013. Comprehensive control of human papillomavirus infections and related diseases. Vaccine, v. 31 Suppl 7
Doi: http://doi.org/10.1016/j.vaccine.2013.10.003
Bosch, FX., Broker, TR., Forman, D., Moscicki, A-B., Gillison, ML., Doorbar, J., Stern, PL., Stanley, M., Arbyn, M., Poljak, M., Cuzick, J., Castle, PE., Schiller, JT., Markowitz, LE., Fisher, WA., Canfell, K., Denny, LA., Franco, EL., Steben, M., Kane, MA., Schiffman, M., Meijer, CJLM., Sankaranarayanan, R., Castellsagué, X., Kim, JJ., Brotons, M., Alemany, L., Albero, G., Diaz, M., de Sanjosé, S. and authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012, , 2013. Comprehensive control of human papillomavirus infections and related diseases. Vaccine, v. 31 Suppl 5
Doi: http://doi.org/10.1016/j.vaccine.2013.10.001
Bosch, FX., Broker, TR., Forman, D., Moscicki, A-B., Gillison, ML., Doorbar, J., Stern, PL., Stanley, M., Arbyn, M., Poljak, M., Cuzick, J., Castle, PE., Schiller, JT., Markowitz, LE., Fisher, WA., Canfell, K., Denny, LA., Franco, EL., Steben, M., Kane, MA., Schiffman, M., Meijer, CJLM., Sankaranarayanan, R., Castellsagué, X., Kim, JJ., Brotons, M., Alemany, L., Albero, G., Diaz, M., de Sanjosé, S. and ICO Monograph 'Comprehensive Control of HPV Infections and Related Diseases' Vaccine Volume 30, Supplement 5, 2012, , 2013. Comprehensive control of human papillomavirus infections and related diseases. Vaccine, v. 31 Suppl 6
Doi: http://doi.org/10.1016/j.vaccine.2013.10.002
Xavier Bosch, F., Broker, TR., Forman, D., Moscicki, A-B., Gillison, ML., Doorbar, J., Stern, PL., Stanley, M., Arbyn, M., Poljak, M., Cuzick, J., Castle, PE., Schiller, JT., Markowitz, LE., Fisher, WA., Canfell, K., Denny, LA., Franco, EL., Steben, M., Kane, MA., Schiffman, M., Meijer, CJLM., Sankaranarayanan, R., Castellsague, X., Kim, JJ., Brotons, M., Alemany, L., Albero, G., Diaz, M. and de Sanjose, S., 2013. Comprehensive Control of Human Papillomavirus Infections and Related Diseases VACCINE, v. 31
Doi: http://doi.org/10.1016/j.vaccine.2013.07.026
Hawkins, MG., Winder, DM., Ball, SLR., Vaughan, K., Sonnex, C., Stanley, MA., Sterling, JC. and Goon, PKC., 2013. Detection of specific HPV subtypes responsible for the pathogenesis of condylomata acuminata. Virol J, v. 10
Doi: http://doi.org/10.1186/1743-422X-10-137
Hanning, JE., Saini, HK., Murray, MJ., Caffarel, MM., van Dongen, S., Ward, D., Barker, EM., Scarpini, CG., Groves, IJ., Stanley, MA., Enright, AJ., Pett, MR. and Coleman, N., 2013. Depletion of HPV16 early genes induces autophagy and senescence in a cervical carcinogenesis model, regardless of viral physical state. J Pathol, v. 231
Doi: http://doi.org/10.1002/path.4244
2012
Stanley, MA., Winder, DM., Sterling, JC. and Goon, PKC., 2012. HPV infection, anal intra-epithelial neoplasia (AIN) and anal cancer: current issues. BMC Cancer, v. 12
Doi: http://doi.org/10.1186/1471-2407-12-398
Franco, EL., de Sanjose, S., Broker, TR., Stanley, MA., Chevarie-Davis, M., Isidean, SD. and Schiffman, M., 2012. Human Papillomavirus and Cancer Prevention: Gaps in Knowledge and Prospects for Research, Policy, and Advocacy VACCINE, v. 30
Doi: http://doi.org/10.1016/j.vaccine.2012.06.092
Doorbar, J., Quint, W., Banks, L., Bravo, IG., Stoler, M., Broker, TR. and Stanley, MA., 2012. The Biology and Life-Cycle of Human Papillomaviruses VACCINE, v. 30
Doi: http://doi.org/10.1016/j.vaccine.2012.06.083
2011
Shafi, MI., Petry, U., Bosch, XF., Gissman, L., Kocken, M., Helmerhorst, TJM., Stanley, M. and Nazeer, S., 2011. European Consensus Statement on "HPV Vaccination and Colposcopy" J LOW GENIT TRACT DI, v. 15
Doi: http://doi.org/10.1097/LGT.0b013e318222b2c4
Ball, SLR., Winder, DM., Vaughan, K., Hanna, N., Levy, J., Sterling, JC., Stanley, MA. and Goon, PKC., 2011. Analyses of human papillomavirus genotypes and viral loads in anogenital warts. J Med Virol, v. 83
Doi: http://doi.org/10.1002/jmv.22111
Sudhoff, HH., Schwarze, HP., Winder, D., Steinstraesser, L., Görner, M., Stanley, M. and Goon, PKC., 2011. Evidence for a causal association for HPV in head and neck cancers European Archives of Oto-Rhino-Laryngology,
Crawford, R., Grignon, A-L., Kitson, S., Winder, DM., Ball, SLR., Vaughan, K., Stanley, MA., Sterling, JC. and Goon, PKC., 2011. High prevalence of HPV in non-cervical sites of women with abnormal cervical cytology. BMC Cancer, v. 11
Doi: http://doi.org/10.1186/1471-2407-11-473
Sudhoff, HH., Schwarze, HP., Winder, D., Steinstraesser, L., Görner, M., Stanley, M. and Goon, PKC., 2011. Evidence for a causal association for HPV in head and neck cancers European Archives of Oto-Rhino-Laryngology, v. 268
Doi: http://doi.org/10.1007/s00405-011-1714-8
2010
Woo, YL., van den Hende, M., Sterling, JC., Coleman, N., Crawford, RAF., Kwappenberg, KMC., Stanley, MA. and van der Burg, SH., 2010. A prospective study on the natural course of low-grade squamous intraepithelial lesions and the presence of HPV16 E2-, E6- and E7-specific T-cell responses. Int J Cancer, v. 126
Doi: http://doi.org/10.1002/ijc.24804
Gray, E., Pett, MR., Ward, D., Winder, DM., Stanley, MA., Roberts, I., Scarpini, CG. and Coleman, N., 2010. In vitro progression of human papillomavirus 16 episome-associated cervical neoplasia displays fundamental similarities to integrant-associated carcinogenesis. Cancer Res, v. 70
Doi: http://doi.org/10.1158/0008-5472.CAN-09-3335
Stanley, M., 2010. HPV VACCINES: AN OVERVIEW ACTA CYTOL, v. 54
O'Mahony, C., Yesudian, PD. and Stanley, M., 2010. Imiquimod use in the genital area and development of lichen sclerosus and lichen planus INT J STD AIDS, v. 21
Doi: http://doi.org/10.1258/ijsa.2009.009154
2009
Winder, DM., Ball, SLR., Vaughan, K., Hanna, N., Woo, YL., Fränzer, J-T., Sterling, JC., Stanley, MA., Sudhoff, H. and Goon, PKC., 2009. Sensitive HPV detection in oropharyngeal cancers. BMC Cancer, v. 9
Doi: http://doi.org/10.1186/1471-2407-9-440
Stanley, M., 2009. Immunobiology of genital HPV infection CME Journal of Gynecologic Oncology, v. 14
Stanley, M., 2009. HPV genital tract infection: Molecular pathogenesis CME Journal of Gynecologic Oncology, v. 14
Goon, PKC., Stanley, MA., Ebmeyer, J., Steinsträsser, L., Upile, T., Jerjes, W., Bernal-Sprekelsen, M., Görner, M. and Sudhoff, HH., 2009. HPV & head and neck cancer: a descriptive update. Head Neck Oncol, v. 1
Doi: http://doi.org/10.1186/1758-3284-1-36
Heaps, A., Hanna, N., Stanley, M. and Goon, P., 2009. Ex Vivo Analyses of Ano-genital Wart Lymphocytes to Study the Human Papillomavirus Immune Response ACTA DERM-VENEREOL, v. 89
Doi: http://doi.org/10.2340/00015555-0637
Stanley, MA., 2009. Immune responses to human papilloma viruses. Indian J Med Res, v. 130
Stanley, M., 2009. Early age of sexual debut: a risky experience J FAM PLAN REPROD H, v. 35
2008
Roberts, I., Ng, G., Foster, N., Stanley, M., Herdman, MT., Pett, MR., Teschendorff, A. and Coleman, N., 2008. Critical evaluation of HPV16 gene copy number quantification by SYBR green PCR. BMC Biotechnol, v. 8
Doi: http://doi.org/10.1186/1472-6750-8-57
Stanley, M., Gissmann, L. and Nardelli-Haefliger, D., 2008. Immunobiology of Human Papillomavirus Infection and Vaccination - Implications for Second Generation Vaccines VACCINE, v. 26
Doi: http://doi.org/10.1016/j.vaccine.2008.05.066
Woo, YL., Sterling, J., Crawford, R., van der Burg, SH., Coleman, N. and Stanley, M., 2008. FOXP3 immunohistochemistry on formalin-fixed paraffin-embedded tissue: poor correlation between different antibodies. J Clin Pathol, v. 61
Doi: http://doi.org/10.1136/jcp.2008.056200
Skinner, SR., Garland, SM., Stanley, MA., Pitts, M. and Quinn, MA., 2008. Human papillomavirus vaccination for the prevention of cervical neoplasia: is it appropriate to vaccinate women older than 26? MED J AUSTRALIA, v. 188
Goon, P., Sonnex, C., Jani, P., Stanley, M. and Sudhoff, H., 2008. Recurrent respiratory papillomatosis: an overview of current thinking and treatment EUR ARCH OTO-RHINO-L, v. 265
Doi: http://doi.org/10.1007/s00405-007-0546-z
Stanley, M., 2008. The epidemiology and burden of HPV disease. Nursing times, v. 104
Woo, YL., Sterling, JC., Damay, I., Coleman, N., Crawford, R., van der Burg, SH. and Stanley, M., 2008. Characterising the local immune responses in cervical intraepithelial neoplasia: a cross-sectional and longitudinal analysis British Journal of Obstetrics and Gynaecology, v. 115
Doi: http://doi.org/10.1111/j.1471-0528.2008.01936.x
Woo, YL., Sterling, JC., Crawford, R., van der Burg, SH., Coleman, N. and Stanley, M., 2008. FOXP3 immunohistochemistry on formalin-fixed paraffin-embedded tissue: poor correlation between different antibodies Journal of Clinical Pathology, v. 61
Doi: http://doi.org/10.1136/jcp.2008.056200
Dall, KL., Scarpini, CG., Roberts, I., Winder, DM., Stanley, MA., Muralidhar, B., Herdman, MT., Pett, MR. and Coleman, N., 2008. Characterization of naturally occurring HPV16 integration sites isolated from cervical keratinocytes under noncompetitive conditions. Cancer Res, v. 68
Doi: http://doi.org/10.1158/0008-5472.CAN-08-1741
Woo, YL., Sterling, J., Damay, I., Coleman, N., Crawford, R., van der Burg, SH. and Stanley, M., 2008. Characterising the local immune responses in cervical intraepithelial neoplasia: a cross-sectional and longitudinal analysis. BJOG, v. 115
Doi: http://doi.org/10.1111/j.1471-0528.2008.01936.x
2007
Stanley, M., 2007. Prophylactic HPV vaccines DRUGS TODAY, v. 43
Winder, DM., Pett, MR., Foster, N., Shivji, MKK., Herdman, MT., Stanley, MA., Venkitaraman, AR. and Coleman, N., 2007. An increase in DNA double-strand breaks, induced by Ku70 depletion, is associated with human papillomavirus 16 episome loss and de novo viral integration events. J Pathol, v. 213
Doi: http://doi.org/10.1002/path.2206
Stanley, M., 2007. HPV vaccines: where are we now? J FAM PLAN REPROD H, v. 33
Woo, YL., Damay, I., Stanley, M., Crawford, R. and Sterling, J., 2007. The use of HPV Linear Array Assay for multiple HPV typing on archival frozen tissue and DNA specimens J VIROL METHODS, v. 142
Doi: http://doi.org/10.1016/j.jviromet.2007.01.029
Woo, YL., Damay, I., Stanley, M., Crawford, R. and Sterling, JC., 2007. The use of HPV Linear Array Assay for multiple HPV typing on archival frozen tissue and DNA specimens Journal of Virological Methods, v. 142
2006
Herdman, MT., Pett, MR., Roberts, I., Alazawi, WOF., Teschendorff, AE., Zhang, XY., Stanley, MA. and Coleman, N., 2006. Interferon-beta treatment of cervical keratinocytes naturally infected with human papillomavirus 16 episomes promotes rapid reduction in episome numbers and emergence of latent integrants CARCINOGENESIS, v. 27
Doi: http://doi.org/10.1093/carcin/bg1172
Herdman, MT., Pett, MR., Roberts, I., Alazawi, WOF., Teschendorff, AE., Zhang, X-Y., Stanley, MA. and Coleman, N., 2006. Interferon-beta treatment of cervical keratinocytes naturally infected with human papillomavirus 16 episomes promotes rapid reduction in episome numbers and emergence of latent integrants. Carcinogenesis, v. 27
Doi: http://doi.org/10.1093/carcin/bgl172
Pett, MR., Herdman, MT., Palmer, RD., Yeo, GSH., Shivji, MK., Stanley, MA. and Coleman, N., 2006. Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response P NATL ACAD SCI USA, v. 103
Doi: http://doi.org/10.1073/pnas.0600078103
Jain, S., Moore, RA., Anderson, DM., Gough, GW. and Stanley, MA., 2006. Cell-mediated immune responses to COPV early proteins. Virology, v. 356
Doi: http://doi.org/10.1016/j.virol.2006.07.032
2005
Johnston, KB., Monteiro, JM., Schultz, LD., Chen, L., Wang, FB., Ausensi, VA., Dell, EC., Santos, EB., Moore, RA., Palker, TJ., Stanley, MA. and Jansen, KU., 2005. Protection of beagle dogs from mucosal challenge with canine oral papillomavirus by immunization with recombinant adenoviruses expressing codon-optimized early genes VIROLOGY, v. 336
Doi: http://doi.org/10.1016/j.virol.2005.03.022
Johnston, KB., Monteiro, JM., Schultz, LD., Chen, L., Wang, F., Ausensi, VA., Dell, EC., Santos, EB., Moore, RA., Palker, TJ., Stanley, MA. and Jansen, KU., 2005. Protection of beagle dogs from mucosal challenge with canine oral papillomavirus by immunization with recombinant adenoviruses expressing codon-optimized early genes Virology, v. 336
Doi: http://doi.org/10.1016/j.virol.2005.03.022
Stanley, M., 2005. The end for genital human papillomavirus infections? LANCET ONCOL, v. 6
Stanley, MA., 2005. HPV vaccines - Reply J FAM PLAN REPROD H, v. 31
2004
Alazawi, W., Pett, M., Strauss, S., Moseley, R., Gray, J., Stanley, M. and Coleman, N., 2004. Genomic imbalances in 70 snap-frozen cervical squamous intraepithelial lesions: associations with lesion grade, state of the HPV16 E2 gene and clinical outcome. Br J Cancer, v. 91
Doi: http://doi.org/10.1038/sj.bjc.6602237
Pett, MR., Alazawi, WOF., Roberts, I., Dowen, S., Smith, DI., Stanley, MA. and Coleman, N., 2004. Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes. Cancer Res, v. 64
Doi: http://doi.org/10.1158/0008-5472.can-03-3214
Chakrabarti, O., Veeraraghavalu, K., Tergaonkar, V., Liu, Y., Androphy, EJ., Stanley, MA. and Krishna, S., 2004. Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras J VIROL, v. 78
Chakrabarti, O., Veeraraghavalu, K., Tergaonkar, V., Liu, Y., Androphy, EJ., Stanley, MA. and Krishna, S., 2004. Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by Notch signaling and oncogenic Ras Journal of Virology, v. 78
Doi: http://doi.org/10.1128/JVI.78.11.5934-5945.2004
Veeraraghavalu, K., Pett, M., Kumar, RV., Nair, P., Rangarajan, A., Stanley, MA. and Krishna, S., 2004. Papillomavirus-mediated neoplastic progression is associated with reciprocal changes in Jagged1 and manic fringe expression linked to notch activation J VIROL, v. 78
Doi: http://doi.org/10.1128/JVI.78.16.8687.8700.2004
Stanley, MA., 2004. Human papillomavirus (HPV) vaccines: prospects for eradicating cervical cancer J FAM PLAN REPROD H, v. 30
2003
Alazawi, WOF., Morris, LS., Stanley, MA., Garrod, DR. and Coleman, N., 2003. Altered expression of desmosomal components in high-grade squamous intraepithelial lesions of the cervix. Virchows Arch, v. 443
Doi: http://doi.org/10.1007/s00428-003-0771-9
Dowen, SE., Scott, A., Mukherjee, G. and Stanley, MA., 2003. Overexpression of Skp2 in carcinoma of the cervix does not correlate inversely with p27 expression. Int J Cancer, v. 105
Doi: http://doi.org/10.1002/ijc.11066
Dowen, SE., Scott, A., Mukherjee, G. and Stanley, MA., 2003. Overexpression of Skp2 in carcinoma of the cervix does not correlate inversely with p27 expression International Journal of Cancer, v. 105
Doi: http://doi.org/10.1002/ijc.11066
Anderson, DM., Stanley, MA. and White, RAS., 2003. Canine keratinocyte culture and use of a cultured epidermal autograft in a dog VET COMP ORTHOPAED, v. 16
Moore, RA., Walcott, S., White, KL., Anderson, DM., Jain, S., Lloyd, A., Topley, P., Thomsen, L., Gough, GW. and Stanley, MA., 2003. Therapeutic immunisation with COPV early genes by epithelial DNA delivery. Virology, v. 314
Doi: http://doi.org/10.1016/s0042-6822(03)00465-3
Stanley, M., 2003. Untitled - Letter to the editor - Reply ISIS, v. 94
Baldwin, PJ., van der Burg, SH., Boswell, CM., Offringa, R., Hickling, JK., Dobson, J., Roberts, JSC., Latimer, JA., Moseley, RP., Coleman, N., Stanley, MA. and Sterling, JC., 2003. Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia. Clin Cancer Res, v. 9
Stanley, M., 2003. Antibody reactivity to HPV E6 and E7 oncoproteins and early diagnosis of invasive cervical cancer AM J OBSTET GYNECOL, v. 188
Doi: http://doi.org/10.1067/mob.2003.97
Dowen, SE., Neutze, DM., Pett, MR., Cottage, A., Stern, P., Coleman, N. and Stanley, MA., 2003. Amplification of chromosome 5p correlates with increased expression of Skp2 in HPV-immortalized keratinocytes. Oncogene, v. 22
Doi: http://doi.org/10.1038/sj.onc.1206296
2002
Stanley, MA., 2002. Human papillomavirus vaccines. Curr Opin Mol Ther, v. 4
Alazawi, W., Pett, M., Freeman, T., Stanley, M. and Coleman, N., 2002. Changes in host cell genome and transcriptome associated with integration of HPV 16 in cervical keratinocytes J PATHOL, v. 198
Moore, RA., Nicholls, PK., Santos, EB., Gough, GW. and Stanley, MA., 2002. Absence of canine oral papillomavirus DNA following prophylactic L1 particle-mediated immunotherapeutic delivery vaccination. J Gen Virol, v. 83
Doi: http://doi.org/10.1099/0022-1317-83-9-2299
Moore, RA., Santos, EB., Nicholls, PK., White, KL., Anderson, DM., Lloyd, A., Topley, P., Romanos, M., Thomsen, L., Parmar, V., Walcott, S., Gough, GW. and Stanley, MA., 2002. Intraepithelial DNA immunisation with a plasmid encoding a codon optimised COPV E1 gene sequence, but not the wild-type gene sequence completely protects against mucosal challenge with infectious COPV in beagles. Virology, v. 304
Doi: http://doi.org/10.1006/viro.2002.1726
Sinclair, AM., Bench, AJ., Bloor, AJC., Li, J., Göttgens, B., Stanley, ML., Miller, J., Piltz, S., Hunter, S., Nacheva, EP., Sanchez, MJ. and Green, AR., 2002. Rescue of the lethal scl<sup>-/-</sup> phenotype by the human SCL locus Blood, v. 99
Doi: http://doi.org/10.1182/blood.V99.11.3931
Alazawi, W., Pett, M., Arch, B., Scott, L., Freeman, T., Stanley, MA. and Coleman, N., 2002. Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16. Cancer Res, v. 62
2001
Nicholls, PK., Doorbar, J., Moore, RA., Peh, W., Anderson, DM. and Stanley, MA., 2001. Detection of viral DNA and E4 protein in basal keratinocytes of experimental canine oral papillomavirus lesions. Virology, v. 284
Doi: http://doi.org/10.1006/viro.2001.0868
Cottage, A., Dowen, S., Roberts, I., Pett, M., Coleman, N. and Stanley, M., 2001. Early genetic events in HPV immortalised keratinocytes. Genes Chromosomes Cancer, v. 30
Doi: http://doi.org/10.1002/1098-2264(2000)9999:9999<::aid-gcc1060>3.0.co;2-x
Mukherjee, G., Freeman, A., Moore, R., Kumaraswamy, , Devi, KU., Morris, LS., Coleman, N., Dilworth, S., Prabhakaran, PS. and Stanley, MA., 2001. Biologic factors and response to radiotherapy in carcinoma of the cervix INT J GYNECOL CANCER, v. 11
Li, YJ., Pak, BJ., Higgins, RR., Lu, SJ. and Ben-David, Y., 2001. Contiguous arrangement of p45 NFE2, HnRNP A1, and HP1α on mouse chromosome 15 and human chromosome 12: Evidence for suppression of these genes due to retroviral integration within the Fli-2 locus Genes Chromosomes and Cancer, v. 30
Doi: http://doi.org/10.1002/1098-2264(2000)9999:9999<::AID-GCC1058>3.0.CO;2-A
Nicholls, PK., Moore, PF., Anderson, DM., Moore, RA., Parry, NR., Gough, GW. and Stanley, MA., 2001. Regression of canine oral papillomas is associated with infiltration of CD4+ and CD8+ lymphocytes. Virology, v. 283
Doi: http://doi.org/10.1006/viro.2000.0789
Stanley, MA., Moore, RA., Nicholls, PK., Santos, EB., Thomsen, L., Parry, N., Walcott, S. and Gough, G., 2001. Intra-epithelial vaccination with COPV L1 DNA by particle-mediated DNA delivery protects against mucosal challenge with infectious COPV in beagle dogs. Vaccine, v. 19
Doi: http://doi.org/10.1016/s0264-410x(00)00533-8
Mukherjee, G., Freeman, A., Moore, R., Kumaraswamy, , Devi, KU., Morris, LS., Coleman, N., Dilworth, S., Prabhakaran, PS. and Stanley, MA., 2001. Biologic factors and response to radiotherapy in carcinoma of the cervix International Journal of Gynecological Cancer, v. 11
Doi: http://doi.org/10.1046/j.1525-1438.2001.01014.x
2000
Arany, I., Tyring, SK., Brysk, MM., Stanley, MA., Tomai, MA., Miller, RL., Smith, MH., McDermott, DJ. and Slade, HB., 2000. Correlation between pretreatment levels of interferon response genes and clinical responses to an immune response modifier (Imiquimod) in genital warts ANTIMICROB AGENTS CH, v. 44
López, MC. and Stanley, MA., 2000. Cytokine profile of draining lymph node lymphocytes in mice grafted with syngeneic keratinocytes expressing human papillomavirus type 16 E7 protein. J Gen Virol, v. 81
Doi: http://doi.org/10.1099/0022-1317-81-5-1175
1999
Arany, I., Tyring, SK., Stanley, MA., Tomai, MA., Miller, RL., Smith, MH., McDermott, DJ. and Slade, HB., 1999. Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5% ANTIVIR RES, v. 43
Pett, MR., Roberts, IR., Stanley, MA. and Coleman, N., 1999. The cell line W12 as a model for investigation of genomic events associated with the progression of cervical squamous cell carcinoma. AM J HUM GENET, v. 65
Nicholls, PK., Klaunberg, BA., Moore, RA., Santos, EB., Parry, NR., Gough, GW. and Stanley, MA., 1999. Naturally occurring, nonregressing canine oral papillomavirus infection: Host immunity, virus characterization, and experimental infection VIROLOGY, v. 265
1998
Cubie, HA., Plumstead, M., Zhang, W., de Jesus, O., Duncan, LA. and Stanley, MA., 1998. Presence of antibodies to human papillomavirus virus-like particles (VLPs) in 11-13-year-old schoolgirls J MED VIROL, v. 56
Zhang, W., Carmichael, J., Ferguson, J., Inglis, S., Ashrafian, H. and Stanley, M., 1998. Expression of human papillomavirus type 16 L1 protein in Escherichia coli: denaturation, renaturation, and self-assembly of virus-like particles in vitro. Virology, v. 243
Doi: http://doi.org/10.1006/viro.1998.9050
Cubie, HA., Plumstead, M., Zhang, W., De Jesus, O., Duncan, LA. and Stanley, MA., 1998. Presence of antibodies to human papillomavirus virus-like particles (VLPs) in 11-13-year-old schoolgirls Journal of Medical Virology, v. 56
Doi: http://doi.org/10.1002/(SICI)1096-9071(199811)56:3<210::AID-JMV6>3.0.CO;2-A
Masterson, PJ., Stanley, MA., Lewis, AP. and Romanos, MA., 1998. A C-terminal helicase domain of the human papillomavirus E1 protein binds E2 and the DNA polymerase alpha-primase p68 subunit. J Virol, v. 72
Doi: http://doi.org/10.1128/JVI.72.9.7407-7419.1998
1997
Stanley, M., 1997. ands, North Queensland, Australia, 6-9 December 1996 ... MOL MED TODAY, v. 3
Wells, JCK., Stanley, M., Laidlaw, A., Day, JME., Stafford, M. and Davies, PSW., 1997. Investigation of the relationship between infant temperament and later body composition INT J OBESITY, v. 21
Stanley, M., 1997. Genital human papillomaviruses - Prospects for vaccination CURR OPIN INFECT DIS, v. 10
Ngan, HYS., Tsao, SW., Liu, SS. and Stanley, M., 1997. Abnormal expression and mutation of p53 in cervical cancer - A study at protein, RNA and DNA levels GENITOURIN MED, v. 73
Bartholomew, JS., Glenville, S., Sarkar, S., Burt, DJ., Stanley, MA., RuizCabello, F., Jin, CG., Garrido, F. and Stern, PL., 1997. Integration of high-risk human papillomavirus DNA is linked to the down-regulation of class I human leukocyte antigens by steroid hormones in cervical tumor cells CANCER RES, v. 57
DietrichGoetz, W., Kennedy, IM., Levins, B., Stanley, MA. and Clements, JB., 1997. A cellular 65-kDa protein recognizes the negative regulatory element of human papillomavirus late mRNA P NATL ACAD SCI USA, v. 94
Stanley, MA., Masterson, PJ. and Nicholls, PK., 1997. In vitro and animal models for antiviral therapy in papillomavirus infections ANTIVIR CHEM CHEMOTH, v. 8
Ngan, HYS., Tsao, SW., Liu, SS. and Stanley, M., 1997. Abnormal expression and mutation of p53 in cervical cancer - A study at protein, RNA and DNA levels Sexually Transmitted Infections, v. 73
Doi: http://doi.org/10.1136/sti.73.1.54
1996
Wu, R., Coleman, N. and Stanley, M., 1996. Different susceptibility of cervical keratinocytes containing human papillomavirus to cell-mediated cytotoxicity CHINESE MED J-PEKING, v. 109
Loughran, O., Malliri, A., Owens, D., Gallimore, PH., Stanley, MA., Ozanne, B., Frame, MC. and Parkinson, EK., 1996. Association of CDKN2A/p16(INK4A) with human head and neck keratinocyte replicative senescence: Relationship of dysfunction to immortality and neoplasia ONCOGENE, v. 13
1995
Johnsen, CK., Stanley, M. and Norrild, B., 1995. Analysis of human papillomavirus type 16 E5 oncogene expression in vitro and from bicistronic messenger RNAs INTERVIROLOGY, v. 38
STANLEY, M., PARIKH, J., CHAMBERS, M., HIBMA, M. and ZHANG, W., 1995. SEROLOGICAL RESPONSES TO HPV 16 E7 PROTEIN IN A MOUSE MODEL J CELL BIOCHEM,
Raj, K. and Stanley, MA., 1995. The ATP-binding and ATPase activities of human papillomavirus type 16 E1 are significantly weakened by the absence of prolines in its ATP-binding domain. J Gen Virol, v. 76 ( Pt 12)
Doi: http://doi.org/10.1099/0022-1317-76-12-2949
HIBMA, MH., RAJ, K., ELY, SJ., STANLEY, M. and CRAWFORD, L., 1995. THE INTERACTION BETWEEN HUMAN PAPILLOMAVIRUS TYPE-16 E1 AND E2 PROTEINS IS BLOCKED BY AN ANTIBODY TO THE N-TERMINAL REGION OF E2 EUR J BIOCHEM, v. 229
1994
NGAN, HYS., STANLEY, M., LIU, SS. and MA, HK., 1994. HPV AND P53 IN CERVICAL-CANCER GENITOURIN MED, v. 70
Chambers, MA., Wei, Z., Coleman, N., Nash, AA. and Stanley, MA., 1994. "Natural" presentation of human papillomavirus type-16 E7 protein to immunocompetent mice results in antigen-specific sensitization or sustained unresponsiveness. Eur J Immunol, v. 24
Doi: http://doi.org/10.1002/eji.1830240337
Stanley, M., Coleman, N. and Chambers, M., 1994. The host response to lesions induced by human papillomavirus. Ciba Found Symp, v. 187
Coleman, N. and Stanley, MA., 1994. Expression of the myelomonocytic antigens CD36 and L1 by keratinocytes in squamous intraepithelial lesions of the cervix. Hum Pathol, v. 25
Doi: http://doi.org/10.1016/0046-8177(94)90174-0
Coleman, N., Birley, HD., Renton, AM., Hanna, NF., Ryait, BK., Byrne, M., Taylor-Robinson, D. and Stanley, MA., 1994. Immunological events in regressing genital warts. Am J Clin Pathol, v. 102
Doi: http://doi.org/10.1093/ajcp/102.6.768
Chambers, MA., Stacey, SN., Arrand, JR. and Stanley, MA., 1994. Delayed-type hypersensitivity response to human papillomavirus type 16 E6 protein in a mouse model. J Gen Virol, v. 75 ( Pt 1)
Doi: http://doi.org/10.1099/0022-1317-75-1-165
1993
COLEMAN, N., FOX, SB., MICHIE, CA., SCHALL, TJ. and STANLEY, MA., 1993. LYMPHOCYTE TRAFFICKING TO THE CERVIX IN LOW AND HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESIONS J CELL BIOCHEM,
STANLEY, MA. and CHAMBERS, MA., 1993. A DELAYED-TYPE HYPERSENSITIVITY RESPONSE TO HUMAN PAPILLOMAVIRUS TYPE-16 (HPV16) PROTEINS J CELL BIOCHEM,
Sterling, JC., Skepper, JN. and Stanley, MA., 1993. Immunoelectron microscopical localization of human papillomavirus type 16 L1 and E4 proteins in cervical keratinocytes cultured in vivo. J Invest Dermatol, v. 100
Doi: http://doi.org/10.1111/1523-1747.ep12462790
Coleman, N., Greenfield, IM., Hare, J., Kruger-Gray, H., Chain, BM. and Stanley, MA., 1993. Characterization and functional analysis of the expression of intercellular adhesion molecule-1 in human papillomavirus-related disease of cervical keratinocytes. Am J Pathol, v. 143
McLean, CS., Sterling, JC., Mowat, J., Nash, AA. and Stanley, MA., 1993. Delayed-type hypersensitivity response to the human papillomavirus type 16 E7 protein in a mouse model Journal of General Virology, v. 74
McLean, CS., Sterling, JS., Mowat, J., Nash, AA. and Stanley, MA., 1993. Delayed-type hypersensitivity response to the human papillomavirus type 16 E7 protein in a mouse model. J Gen Virol, v. 74 ( Pt 2)
Doi: http://doi.org/10.1099/0022-1317-74-2-239
1992
LEARY, T., JONES, PL., APPLEBY, M., BLIGHT, A., PARKINSON, K. and STANLEY, M., 1992. EPIDERMAL KERATINOCYTE SELF-RENEWAL IS DEPENDENT UPON DERMAL INTEGRITY J INVEST DERMATOL, v. 99
STOREY, A., GREENFIELD, I., BANKS, L., PIM, D., CROOK, T., CRAWFORD, L. and STANLEY, M., 1992. LACK OF IMMORTALIZING ACTIVITY OF A HUMAN PAPILLOMAVIRUS TYPE-16 VARIANT DNA WITH A MUTATION IN THE E2 GENE ISOLATED FROM NORMAL HUMAN CERVICAL KERATINOCYTES ONCOGENE, v. 7
COLEMAN, N., WILSON, B. and STANLEY, MA., 1992. CELLULAR AND MOLECULAR MECHANISMS INVOLVED IN EFFECTIVE IMMUNE-RESPONSES TO HUMAN PAPILLOMAVIRUS INFECTION IN THE GENITAL-TRACT J PATHOL, v. 168
1991
JONES, PL., GREENFIELD, IM., COLEMAN, N. and STANLEY, MA., 1991. HISTOLOGICAL CHARACTERIZATION OF MOUSE EPIDERMAL KERATINOCYTE CELL-LINES TRANSFECTED WITH ACTIVATED RAS ONCOGENES J PATHOL, v. 163
STANLEY, MA., WILLIAMS, AT. and GREENFIELD, IM., 1991. CHARACTERIZATION OF A CELL-LINE CULTURED FROM A HISTOLOGICALLY NORMAL CERVIX J PATHOL, v. 163
STANLEY, MA., LEARY, T., JONES, PL., BLIGHT, A. and PARKINSON, EK., 1991. EPIDERMAL KERATINOCYTE SELF RENEWAL IS DEPENDENT UPON DERMAL INTEGRITY J INVEST DERMATOL, v. 96
GREENFIELD, I., NICKERSON, J., PENMAN, S. and STANLEY, M., 1991. HUMAN PAPILLOMAVIRUS-16 E7-PROTEIN IS ASSOCIATED WITH THE NUCLEAR MATRIX P NATL ACAD SCI USA, v. 88
MCKENZIE, J., KING, A., HARE, J., FULFORD, T., WILSON, B. and STANLEY, M., 1991. IMMUNOCYTOCHEMICAL CHARACTERIZATION OF LARGE GRANULAR LYMPHOCYTES IN NORMAL CERVIX AND HPV ASSOCIATED DISEASE J PATHOL, v. 165
STERLING, JC., MINSON, AC., STANLEY, MA., GATWARD, G. and SKEPPER, J., 1991. CULTURE OF HUMAN PAPILLOMAVIRUS TYPE-16 CONTAINING KERATINOCYTES INVIVO RESULTING IN THE DEVELOPMENT OF A DIFFERENTIATED EPITHELIUM WITH COMPLETION OF THE VIRUS LIFE-CYCLE J PATHOL, v. 163
JONES, PL., GREENFIELD, IM., COLEMAN, N. and STANLEY, MA., 1991. HISTOLOGICAL CHARACTERIZATION OF MOUSE EPIDERMAL KERATINOCYTE CELL-LINES TRANSFECTED WITH ACTIVATED RAS ONCOGENES J PATHOL, v. 163
1990
Yeoman, H., Munro, AJ. and Stanley, MA., 1990. Rejection of MHC incompatible, Langerhans cell-free epidermal keratinocyte allografts in the rat Regional Immunology, v. 3
McLean, CS., Churcher, MJ., Meinke, J., Smith, GL., Higgins, G., Stanley, M. and Minson, AC., 1990. Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virus. J Clin Pathol, v. 43
Doi: http://doi.org/10.1136/jcp.43.6.488
STANLEY, M., 1990. GENITAL PAPILLOMAVIRUSES, POLYMERASE CHAIN-REACTION AND CERVICAL-CANCER GENITOURIN MED, v. 66
STERLING, J., STANLEY, M., GATWARD, G. and MINSON, T., 1990. PRODUCTION OF HUMAN PAPILLOMAVIRUS TYPE-16 VIRIONS IN A KERATINOCYTE CELL-LINE J VIROL, v. 64
DOORBAR, J., PARTON, A., HARTLEY, K., BANKS, L., CROOK, T., STANLEY, M. and CRAWFORD, L., 1990. DETECTION OF NOVEL SPLICING PATTERNS IN A HPV16-CONTAINING KERATINOCYTE CELL-LINE VIROLOGY, v. 178
CROOK, T., GREENFIELD, I., HOWARD, J. and STANLEY, M., 1990. ALTERATIONS IN GROWTH-PROPERTIES OF HUMAN PAPILLOMA-VIRUS TYPE-16 IMMORTALIZED HUMAN CERVICAL KERATINOCYTE CELL-LINE CORRELATE WITH AMPLIFICATION AND OVEREXPRESSION OF C-MYC ONCOGENE ONCOGENE, v. 5
TINOIS, E., COBBOLD, S., FAURE, M., STANLEY, M. and THIVOLET, J., 1990. CULTURED KERATINOCYTE GRAFTS ARE RECOGNIZED, BUT NOT REJECTED BY CD8+ T-CELLS INVIVO J INVEST DERMATOL, v. 94
Zhou, J., Crawford, L., McLean, L., Sun, X., Stanley, M., Almond, N. and Smith, GL., 1990. Increased antibody responses to human papillomavirus type 16 L1 protein expressed by recombinant vaccinia virus lacking serine protease inhibitor genes Journal of General Virology, v. 71
Doi: http://doi.org/10.1099/0022-1317-71-9-2185
Sterling, JC., Stanley, MA., Gatward, G. and Minson, AC., 1990. Production of human papillomavirus type 16 visions in a keratinocyte cell line. Journal of Virology, v. 64
1989
Yeoman, H., Ramrakha, PS., Sharp, RJ. and Stanley, MA., 1989. The role of antigen-presenting cells in the survival of murine-cultured keratinocyte allografts. Transplant Proc, v. 21
Stanley, MA., Browne, HM., Appleby, M. and Minson, AC., 1989. Properties of a non-tumorigenic human cervical keratinocyte cell line. Int J Cancer, v. 43
Doi: http://doi.org/10.1002/ijc.2910430422
Appleby, MW., Greenfield, IM., Crook, T., Parkinson, EK. and Stanley, MA., 1989. In vivo and in vitro effects of v-fos and EJ-Ha-ras oncogene expression in murine epidermal keratinocytes. Oncogene, v. 4
Yeoman, H., Ramrakha, PS., Sharp, RJ. and Stanley, MA., 1989. The role of antigen-presenting cells in the survival of murine-cultured keratinocyte allografts Transplantation Proceedings, v. 21
Yeoman, H., Anderton, JG. and Stanley, MA., 1989. MHC class II antigen expression is not induced on murine epidermal keratinocytes by interferon-gamma alone or in combination with tumour necrosis factor-alpha. Immunology, v. 66
Crook, T., Almond, N., Murray, A., Stanley, M. and Crawford, L., 1989. Constitutive expression of c-myc oncogene confers hormone independence and enhanced growth-factor responsiveness on cells transformed by human papilloma virus type 16. Proc Natl Acad Sci U S A, v. 86
Doi: http://doi.org/10.1073/pnas.86.15.5713
Ramrakha, PS., Sharp, RJ., Yeoman, H. and Stanley, MA., 1989. The influence of MHC-compatible and MHC-incompatible antigen-presenting cells on the survival of MHC-compatible cultured murine keratinocyte allografts. Transplantation, v. 48
TINOIS, E., COBBOLD, S., FAURE, M., YEOMAN, H. and STANLEY, M., 1989. CULTURED KERATINOCYTE GRAFTS ARE RECOGNIZED, BUT NOT REJECTED BY CD8+ T-CELLS INVIVO EUR J IMMUNOL, v. 19
TINOIS, E., FAURE, M., COBBOLD, S., YEOMAN, H., STANLEY, M. and THIVOLET, J., 1989. CULTURED MURINE EPIDERMAL ALLOGRAFTS INDUCE A PROLONGED SURVIVAL OF FULL THICKNESS SKIN ALLOGRAFTS CLIN RES, v. 37
TINOIS, E., FAURE, M., COBBOLD, S., YEOMAN, H., STANLEY, M. and THIVOLET, J., 1989. CULTURED MURINE EPIDERMAL ALLOGRAFTS INDUCE A PROLONGED SURVIVAL OF FULL THICKNESS SKIN ALLOGRAFTS J INVEST DERMATOL, v. 92
1988
Browne, HM., Churcher, MJ., Stanley, MA., Smith, GL. and Minson, AC., 1988. Analysis of the L1 gene product of human papillomavirus type 16 by expression in a vaccinia virus recombinant. J Gen Virol, v. 69 ( Pt 6)
Doi: http://doi.org/10.1099/0022-1317-69-6-1263
MATLASHEWSKI, G., OSBORN, K., BANKS, L., STANLEY, M. and CRAWFORD, L., 1988. TRANSFORMATION OF PRIMARY HUMAN FIBROBLAST CELLS WITH HUMAN PAPILLOMAVIRUS TYPE-16 DNA AND EJ-RAS INT J CANCER, v. 42
Thorne, KJI., Richardson, BA., Butterworth, AE. and Stanley, M., 1988. Eosinophil-activating factor (EAF) production by a human cell line (ESH 98) stimulated with tumour necrosis factor Immunology, v. 63
VANHERCKENRODE, CM., COLEMAN, DJ., STANLEY, M. and KOCH, GLE., 1988. ANTIBODIES SPECIFIC FOR HELA GLYCOPROTEIN ANTIGENS ARE ALSO SPECIFIC FOR HUMAN ENDOCERVICAL EPITHELIUM BRIT J CANCER, v. 57
1987
HAMMOND, EJ., NG, RLH., STANLEY, MA. and MUNRO, AJ., 1987. PROLONGED SURVIVAL OF CULTURED KERATINOCYTE ALLOGRAFTS IN THE NONIMMUNOSUPPRESSED MOUSE TRANSPLANTATION, v. 44
APPLEBY, MW., STANLEY, MA. and PARKINSON, EK., 1987. THE IDENTIFICATION OF A KERATINOCYTE SUBPOPULATION RESISTANT TO SUSPENSION INDUCED TERMINAL DIFFERENTIATION ANTICANCER RES, v. 7
1986
HAMMOND, EJ., NG, R. and STANLEY, MA., 1986. PROLONGED SURVIVAL OF ALLOGENEIC CULTURED EPIDERMAL KERATINOCYTE SHEETS IN THE MOUSE WITHOUT IMMUNOSUPPRESSION J INVEST DERMATOL, v. 87
PEAT, DS. and STANLEY, MA., 1986. CHROMOSOME-DAMAGE INDUCED BY HERPES-SIMPLEX VIRUS TYPE-1 IN EARLY INFECTION J GEN VIROL, v. 67
BLANK, H., HOWLEY, P., VESSEY, MP., SHAH, KV., COLEMAN, DV., MCCANCE, DJ., LANCSTER, WD., GALLOWAY, DA., GISSMANN, L., ANDROPHY, ET., STEINBERG, BM., STANLEY, M., PFISTER, H. and CAMPO, MS., 1986. EPIDEMIOLOGIC TRENDS AND LEGAL-ASPECTS - GENERAL DISCUSSION CIBA F SYMP, v. 120
1985
DIXON, IS. and STANLEY, MA., 1985. DIFFERENTIATION OF HUMAN CERVICAL EPITHELIA INVIVO AND INVITRO J PATHOL, v. 145
STANLEY, MA., CROWCROFT, NS., QUIGLEY, JP. and PARKINSON, FK., 1985. RESPONSES OF HUMAN CERVICAL KERATINOCYTES INVITRO TO TUMOR PROMOTERS AND DIETHYLSTILBESTROL CARCINOGENESIS, v. 6
1984
DIXON, IS. and STANLEY, MA., 1984. IMMUNOFLUORESCENT STUDIES ON THE CYTOSKELETON OF HUMAN CERVICAL EPITHELIUM INVIVO AND INVITRO EUR J CELL BIOL, v. 33
STANLEY, MA. and DAHLENBURG, K., 1984. THE EFFECT OF CHOLERAGEN AND EPIDERMAL GROWTH-FACTOR ON PROLIFERATION AND MATURATION INVITRO OF HUMAN ECTOCERVICAL CELLS IN VITRO CELL DEV B, v. 20
Dixon, IS. and Stanley, MA., 1984. Immunofluorescent studies of human cervical epithelia in vivo and in vitro using antibodies against specific keratin components Molecular Biology and Medicine, v. 2
STANLEY, MA., JOHNSTONE, SR. and QUIGLEY, JR., 1984. EFFECT DIETHYLSTILBESTROL ON GROWTH OF HUMAN CERVICAL CELLS-INVITRO J PATHOL, v. 142
JOHNSTONE, SRD., STANLEY, MA. and QUIGLEY, JP., 1984. THE EFFECT OF DIETHYLSTILBESTROL ON THE INVITRO GROWTH OF HUMAN ECTOCERVICAL CELLS CARCINOGENESIS, v. 5
1982
STANLEY, MA. and DAHLENBURG, K., 1982. THE EFFECT OF CHOLERA-TOXIN AND EPIDERMAL GROWTH-FACTOR ON THE INVITRO GROWTH OF HUMAN CERVICAL EPITHELIUM J PATHOL, v. 138